MRT Inc. (6034) AI Stock Analysis

• Market Cap: ¥3.91B
• Dividend Yield: N/A
• Average Volume (3M): 2.26K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.01
• Revenue Growth: -2.66%
• EPS Growth: -913.85%
• Country: JP
• Employees: 304
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 32.00
• Shares Outstanding: 5,718,600
• 10 Day Avg. Volume: 2,710
• 30 Day Avg. Volume: 2,256
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥723.00
• Price Target Upside: 3.14% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 53 Neutral
• Price Target: ¥723.00 ▲(3.14% Upside)

The overall stock score is primarily influenced by financial performance challenges, including declining revenue and profitability. Technical analysis provides some positive signals, but valuation remains a significant concern due to negative earnings and lack of dividend yield.

MRT Inc. Business Overview & Revenue Model

Company Description

MRT Inc. operates a medical information platform. The company provides temporary and part-time doctor services; doctor's career change support service; Door., an app to connect network of doctors; Door.into, which provides online health counseling, and online medical care; Pocket Doctor, a telemedicine/health consultation app; groupware for medical offices; FASTCALL that consolidates the functions required for hospital crisis management system as safety confirmation service for medical institution; and Good Doctors, which provides owned media sent by doctors. It also offers nurse and pharmacist recruitment service; human resources introduction service for clinical laboratory engineers, radiologists, and dialysis nurses, as well as for new business openings and succession projects; and recruitment information service for exclusive industrial physicians and contract industrial physicians. In addition, the company engages in employment agency business, opening of business, business succession support business, and PR business, and career support business. Further, it offers services for supporting the operation of medical institutions, such as fund management, utilizing medical fee factoring, payroll calculation for doctors' part-time jobs, and payroll transfer agency services. Additionally, the company sells human umbilical cord-derived stem cell culture supernatant; and provides babysitter services, tax accountant referral service, credit card payment agency service, questionnaire survey request for pharmaceuticals, etc., as well as media coverage cooperation, lecture request, event rescue, etc. It also publishes books on illness and treatment; and offers health maintenance service and member comprehensive compensation systems. The company was formerly known as Medical Research and Technology Co., Ltd and changed its name to MRT Inc. in September 2014. MRT Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

How the Company Makes Money

MRT Inc. generates revenue through its digital platforms that offer a range of services including job placement and recruitment services for medical professionals, advertising and promotional services for healthcare products, and subscription fees for access to specialized medical information. The company partners with healthcare institutions, medical device manufacturers, and pharmaceutical companies to create a robust ecosystem that supports its monetization strategies. Additional revenue streams may include consulting and support services tailored to the needs of healthcare providers.

MRT Inc. Financial Statement Overview

Summary

MRT Inc. is facing financial difficulties with declining revenue and profitability. The income statement shows negative net profit and EBIT margins, and cash flow analysis reveals a significant decline in free cash flow growth. The balance sheet is stable but profitability issues persist.

Income Statement

MRT Inc. shows a concerning decline in revenue and profitability over the recent periods. The TTM data indicates a negative net profit margin of -8.26%, and EBIT margin of -4.15%, reflecting operational challenges. Despite a slight revenue growth of 1.11% in the TTM, the company has faced significant revenue declines in prior years, impacting overall performance.

Balance Sheet

The balance sheet reflects a moderate debt-to-equity ratio of 0.16 in the TTM, indicating manageable leverage. However, the return on equity is negative at -7.77%, highlighting profitability issues. The equity ratio remains stable, suggesting a solid capital structure despite recent financial challenges.

Cash Flow

Cash flow analysis reveals a significant decline in free cash flow growth at -56.11% in the TTM, raising concerns about cash generation capabilities. The operating cash flow to net income ratio is 0.58, indicating some operational cash flow support, but overall cash flow performance has weakened.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.27B	4.17B	5.41B	8.74B	4.47B	2.56B
Gross Profit	2.75B	2.74B	3.27B	5.60B	3.55B	1.76B
EBITDA	174.66M	139.00M	1.10B	3.16B	1.45B	420.18M
Net Income	-265.63M	-309.16M	517.00M	2.16B	774.49M	131.81M
Balance Sheet
Total Assets	6.29B	6.75B	6.47B	8.16B	4.98B	3.31B
Cash, Cash Equivalents and Short-Term Investments	2.19B	2.62B	3.78B	4.90B	1.03B	1.59B
Total Debt	646.35M	1.05B	641.00M	875.86M	1.04B	1.11B
Total Liabilities	1.79B	2.12B	1.76B	3.67B	2.69B	1.75B
Stockholders Equity	4.39B	4.52B	4.58B	4.39B	2.22B	1.52B
Cash Flow
Free Cash Flow	214.58M	462.00M	-208.00M	4.43B	-405.64M	183.97M
Operating Cash Flow	231.74M	503.04M	-193.00M	4.51B	-298.89M	294.97M
Investing Cash Flow	-2.00B	-1.84B	-243.61M	-431.11M	-206.51M	-64.61M
Financing Cash Flow	-194.10M	161.77M	-669.19M	-203.98M	-67.49M	-397.41M

MRT Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 701.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6034, the sentiment is Negative. The current price of 701 is below the 20-day moving average (MA) of 710.95, below the 50-day MA of 707.90, and below the 200-day MA of 706.95, indicating a bearish trend. The MACD of -2.14 indicates Positive momentum. The RSI at 41.69 is Neutral, neither overbought nor oversold. The STOCH value of 17.77 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6034.

MRT Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3671	85 Outperform	¥8.85B	13.67	13.65%	8.15%	26.12%	38.78%
6545	74 Outperform	¥3.51B	15.65	15.49%	1.84%	5.27%	12.22%
6034	53 Neutral	¥3.91B	―	―	―	-2.66%	-913.85%
4438	44 Neutral	¥2.60B	-3.48	-99.33%	―	15.50%	-31.31%
3902	43 Neutral	¥23.55B	-32.19	―	1.08%	-0.58%	-260.22%
3628	40 Neutral	¥6.44B	-2.14	-1782.91%	―	-2.60%	-103.03%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%